share_log

大行评级|TD Cowen:下调诺和诺德目标价至105美元 维持“买入”评级

Major Bank Rating | TD Cowen: Downgraded Novo-Nordisk A/S Target Price to $105, maintaining "Buy" rating.

Gelonghui Finance ·  Dec 23 21:21  · Ratings

On December 23, Glory Holdings reported that TD Cowen has lowered the Target Price for Novo-Nordisk A/S from $155 to $105, maintaining a Buy rating. TD Cowen pointed out that despite the trial results of CagriSema being below expectations, Novo-Nordisk A/S has a strong market position due to its main drugs, the potential of the new CagriSema trials, and a vibrant product line. (Glory Holdings)

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment